688767 博拓生物
按盤價 
41.630 +4.630 (+12.514%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.432 | 2.061 | 7.027 | 4.284 | 33.144 |
| 總資產報酬率 ROA (%) | -0.406 | 1.916 | 6.543 | 3.999 | 29.852 |
| 投入資產回報率 ROIC (%) | -0.429 | 2.051 | 6.942 | 4.189 | 32.497 | 邊際利潤分析 |
| 銷售毛利率 (%) | 47.557 | 46.032 | 52.842 | 50.331 | 53.461 |
| 營業利潤率 (%) | -16.383 | 11.278 | 34.574 | 26.424 | 48.094 |
| 息稅前利潤/營業總收入 (%) | -4.624 | 7.602 | 24.105 | 6.812 | 39.663 |
| 淨利潤/營業總收入 (%) | -11.784 | 10.519 | 29.813 | 23.818 | 40.689 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 101.371 | 65.119 | 101.594 | 123.529 | 105.381 |
| 價值變動淨收益/利潤總額(%) | 6.577 | 8.634 | 3.616 | 2.917 | 1.647 |
| 營業外收支淨額/利潤總額(%) | -1.519 | -1.697 | 0.776 | -0.817 | -1.380 | 償債能力分析 |
| 流動比率 (X) | 14.112 | 10.517 | 10.514 | 13.966 | 13.066 |
| 速動比率 (X) | 13.472 | 10.076 | 10.103 | 13.301 | 12.275 |
| 資產負債率 (%) | 4.897 | 6.622 | 7.293 | 6.157 | 6.879 |
| 帶息債務/全部投入資本 (%) | 0.102 | 0.229 | -0.138 | 1.683 | 1.666 |
| 股東權益/帶息債務 (%) | 97,491.705 | 43,456.457 | -72,239.230 | 5,818.747 | 5,859.963 |
| 股東權益/負債合計 (%) | 1,939.059 | 1,409.179 | 1,269.576 | 1,520.734 | 1,353.085 |
| 利息保障倍數 (X) | -0.402 | -2.180 | -2.245 | -0.351 | -5.100 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 88.781 | 75.065 | 51.274 | 41.004 | 17.585 |
| 存貨周轉天數 (天) | 135.764 | 106.519 | 117.856 | 192.239 | 56.333 |
| 備註： | 即時報價更新時間為 06/07/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
